Pharmacokinetics and milk distribution characteristics of orbifloxacin following intravenous and intramuscular injection in lactating ewes

Journal of Veterinary Pharmacology and Therapeutics

Volumn 32, Issue 4, 2009, Pages 338-344

  Goudah, A ^a   Cho, H J ^b   Shin, H C ^b   Shim, J H ^c   Regmi, N L ^d   Shimoda, M ^e   Abd El Aty, A M ^a,b  

^a Cairo University   (Egypt)

^b Konkuk University   (South Korea)

^c Chonnam National University   (South Korea)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ORBIFLOXACIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE TIME EFFECT RELATION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MILK LEVEL; DRUG PENETRATION; DRUG PROTEIN BINDING; EWE; FEMALE; KLEBSIELLA PNEUMONIAE; LACTATION; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PRIORITY JOURNAL; VALIDATION STUDY;

ANIMALS; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; CROSS-OVER STUDIES; FEMALE; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAMUSCULAR; KLEBSIELLA PNEUMONIAE; LACTATION; MILK; SHEEP;

KLEBSIELLA PNEUMONIAE;

EID: 67651251940     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2008.01046.x     Document Type: Article

References (38)

1. Abd El-Aty, A.M. Goudah, A. (2002) Some pharmacokinetic parameters of pefloxacin in lactating goats. Veterinary Research Communications, 26, 553 561.
2. Baggot, J.D. (2001) Pharmacokinetic terms: symbols and units. Journal of Veterinary Pharmacology and Therapeutics, 24, 81 82.
3. Brown, S.A. (1996) Fluorquinolones in animal health. Journal of Veterinary Pharmacology and Therapeutics, 19, 1 14.
4. Carceles, C.M., Villamayor, L., Escudero, E., Marin, P. Fernandez-Varon, E. (2007) Pharmacokinetics and milk penetration of moxifloxacin after intramuscular administration to lactating goats. The Veterinary Journal, 173, 452 455. (Pubitemid 46268285)
5. Cester, C., Schneider, M. Toutain, P.L. (1996) Comparative kinetics of two orally administered fluoroquinolones in dog: enrofloxacin versus marbofloxacin. Revue de Medecine Veterinaire, 147, 703 716.
6. Craig, A.W. Suh, B. (1991) Protein binding and the antibacterial effects. Method for the determination of protein binding. In Antibiotics in laboratory Medicine, 3rd edn. Ed. Lorian, V., pp. 367 402. Williams & Wilkins, Baltimore, Maryland, USA.
7. Davis, J.L., Papich, M.G. Weingarten, A. (2006) The pharmacokinetics of orbifloxacin in the horse following oral and intravenous administration. Journal of Veterinary Pharmacology and Therapeutics, 29, 191 197.
8. Dowling, P.M., Wilson, R.C., Tyler, J.W. Duran, S.H. (1995) Pharmacokinetics of ciprofloxacin in ponies. Journal of Veterinary Pharmacology and Therapeutics, 18, 7 12.
9. Drusano, G.L., Johnson, D.E., Rosen, M. Standiford, H.C. (1993) Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis. Antimicrobial Agents and Chemotherapy, 37, 483 490.
10. Ev Lda, S. Schapoval, E.E. (2002) Microbiological assay for determination of ofloxacin injection. Journal of Pharmaceutical and Biomedical Analysis, 27, 91 96.
11. Fernandez-Varon, E., Villamayor, L., Escudero, E., Espuny, A. Carceles, C.M. (2006) Pharmacokinetics and milk penetration of moxifloxacin after intravenous and subcutaneous administration to lactating goats. The Veterinary Journal, 172, 302 307. (Pubitemid 44159268)
12. Gibaldi, M. Perrier, D. (1982) Non Compartmental Analysis Based on Statistical Moment Theory. Pharmacokinetics, 2nd edn, pp. 409 417. Marcel Dekker, New York.
13. Goudah, A. (2008) Disposition kinetics of moxifloxacin in lactating ewes. The Veterinary Journal, 178, 282 287.
14. Goudah, A., Shin, H.C., Shim, J.H. Abd El-Aty, A.M. (2006) Characterization of the relationship between serum and milk residue disposition of ceftriaxone in lactating ewes. Journal of Veterinary Pharmacology and Therapeutics, 29, 307 312.
15. Haines, G.R., Brown, M.P., Gronwall, R.R., Merritt, K.A. Baltzley, L.K. (2001) Pharmacokinetics of orbifloxacin and its concentration in body fluids and in endometrial tissues of mares. Canadian Journal of Veterinary Research, 65, 181 187.
16. Hannan, P.C., Windsor, G.D., de Jong, A., Schmeer, N. Stegemann, M. (1997) Comparative susceptibilities of various animal-pathogenic mycoplasmas to fluoroquinolones. Antimicrobial Agents and Chemotherapy, 41, 2037 2040.
17. Heinen, E. (2002) Comparative serum pharmacokinetics of the fluoroquinolones enrofloxacin, difloxacin, marbofloxacin, and orbifloxacin in dogs after single oral administration. Journal of Veterinary Pharmacology and Therapeutics, 25, 1 5.
18. Ihrke, P.J., Papich, M.G. Demanuelle, T.C. (1999) The use of fluoroquinolones in veterinary dermatology. Veterinary Dermatology, 10, 193 204.
19. Ingerman, M.J., Pitsakis, P.G., Rosenberg, A.F. Levison, M.E. (1986) The importance of pharmacodynamics in determining the dosing interval in therapy for experimental Pseudomonas endocarditis in the rat. The Journal of Infectious Diseases, 153, 707 714.
20. Jonker, J.W., Merino, G. Musters, S. (2005) The breast cancer resistance protein BCRP(ABCG2) concentrates drugs and carcinogenic xenotoxins into milk. Nature Medicine, 11, 127 129.
21. Kang, S.L., Rybak, M.J., McGrath, B.J., Kaatz, G.W. Seo, S.M. (1994) Pharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin alone and in combination with rifampin, against methicillin-susceptible and -resistant Staphylococcus aureus in an in vitro infection model. Antimicrobial Agents and Chemotherapy, 38, 2702 2709.
22. Klassen, M. Edberg, S.C. (1996) Measurement of antibiotics in human body fluids: techniques and significance. In Antibiotics in Laboratory Medicine, 4th edn. Ed. Lorian, V., pp. 234 243. Williams & Wilkins, Baltimore.
23. Marín, P., Escudero, E., Fernández-Varón, E. Cárceles, C.M. (2007) Pharmacokinetics and milk penetration of orbifloxacin after intravenous, subcutaneous, and intramuscular administration to lactating goats. Journal of Dairy Science, 90, 4219 4225.
24. Martinez, M., McDermott, P. Walker, R. (2007) Pharmacology of the fluoroquinolones: a perspective for the use in domestic animals. The Veterinary Journal, 172, 10 28.
25. Matsumoto, S., Nakai, M., Yoshida, M. Katae, H. (1999) A study of metabolites isolated from urine samples of pigs and calves administered orbifloxacin. Journal of Veterinary Pharmacology and Therapeutics, 22, 286 289.
26. McKellar, Q., Gibson, I., Monteiro, A. Bregante, M. (1999) Pharmacokinetics of enrofloxacin and danofloxacin in plasma, inflammatory exudate, and bronchial secretions of calves following subcutaneous administration. Antimicrobial Agents and Chemotherapy, 43, 1988 1992.
27. Papich, M.G. Riviere, J.E. (2001) Fluoroquinolone antimicrobial drugs. In Veterinary Pharmacology and Therapeutics, 8th edn. Ed. Adams, H.R., pp. 898 917. Iowa State University Press, Ames, IA.
28. Pulido, M.M., Molina, A.J., Merino, G., Mendoza, G., Prieto, J.G. Alvarez, A.I. (2006) Interaction of enrofloxacin with breast cancer resistance protein (BCRP/ABCG2): influence of flavonoids and role in milk secretion in sheep. Journal of Veterinary Pharmacology and Therapeutics, 29, 279 287.
29. Shem-Tov, M., Ziv, G., Glickman, A. Saran, A. (1997) Pharmacokinetics and penetration of marbofloxacin from blood into the milk of cows and ewes. Journal of Veterinary Medicine A, 44, 511 519. (Pubitemid 127525000)
30. Soback, S., Gips, M., Bialer, M. Bor, A. (1994) Effect of lactation on single dose pharmacokinetics of norfloxacin in ewes. Antimicrobial Agents and Chemotherapy, 38, 2336 2339.
31. Spreng, M., Deleforge, J., Thomas, E., Boisrame, B. Drugeon, H. (1995) Antibacterial activity of marbofloxacin. A new fluoroquinolone for veterinary use against canine and feline isolates. Journal of Veterinary Pharmacology and Therapeutics, 18, 284 289.
32. Sullivan, M.C., Cooper, B.W., Nightingale, C.H., Quintiliani, R. Lawlor, M.T. (1993) Evaluation of the efficacy of ciprofloxacin against Streptococcus pneumoniae by using a mouse protection model. Antimicrobial Agents and Chemotherapy, 37, 234 239.
33. Toutan, P.L. Bousquet-Melou, A. (2004) Volumes of distribution. Journal of Veterinary Pharmacology and Therapeutics, 27, 441 453.
34. Turnidge, J. (1999) Pharmacokinetics and pharmacodynamics of fluoroquinolones. Drugs, 58, 29 36.
35. Walker, R.D. (2000) The use of fluoroquinolones for companion animal antimicrobial therapy. Australian Veterinary Journal, 78, 84 90.
36. Yamaoka, K., Nakagawa, T. Uno, T. (1978) Statistical moment in pharmacokinetics. Journal of Pharmacokinetic and Biopharmaceutics, 6, 547 558.
37. Ziv, G., Kurtz, B., Risenberg, R. Glickman, A. (1995) Serum and milk concentrations of apramycin in lactating cows, ewes and goats. Journal of Veterinary Pharmacology and Therapeutics, 18, 346 351.
38. Zlotos, G., Bucker, A., Kinzig-Schippers, M., Sorgel, F. Holzgrabe, U. (1998) Plasma protein binding of gyrase inhibitors. Journal of Pharmaceutical Science, 87, 215 220.